John Barton, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy
Wake Forest
Medical School
Wake Forest University
Residency
Wake Forest University
Fellowship
American Board of Internal Medicine - Oncology
WV State Medical License: 2016 - 2016
NC State Medical License: 2013 - 2016
TN State Medical License: 1997 - 2016
American Board of Internal Medicine: Medical Oncology
Saint Thomas - Rutherford Hospital
Languages: English/Spanish
(615) 396-4100
1700 Medical Center Pkwy
Read MoreA phase I dose escalation study of NK012, an SN-38 incorporating macromolecular polymeric micelle.
Burris, H. A.,Infante, J. R.,Anthony Greco, F.,Thompson, D. S.,Barton, J. H.,Bendell, J. C.,Nambu, Y.,Watanabe, N.,Jones, S. F.; Cancer Chemother. Pharmacol.. 1900 Jan 01.
See more >>A phase Ib study of linsitinib (OSI-906), a dual inhibitor of IGF-1R and IR tyrosine kinase, in combination with everolimus as treatment for patients with refractory m...
Bendell, J. C.,Jones, S. F.,Hart, L.,Spigel, D. R.,Lane, C. M.,Earwood, C.,Infante, J. R.,Barton, J.,Burris, H. A.; Invest New Drugs. 2014 Oct 23.
See more >>22 citations Hormonal therapy plus bevacizumab in postmenopausal patients who have hormone receptor-positive metastatic breast cancer: a phase II Trial of the Sarah Cannon Oncology...
Yardley DA, Burris HA, Clark BL, Shipley D, Rubin M, Barton J, Arrowsmith E, Hainsworth JD; Clin. Breast Cancer. 2011-06-01.
See more >>